Aldeyra Therapeutics, Inc. (ALDX)
1.34
-0.12
(-8.22%)
USD |
NASDAQ |
Sep 11, 16:00
1.355
+0.02
(+1.12%)
After-Hours: 20:00
Aldeyra Therapeutics Total Liabilities (Quarterly) : 9.655M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.655M |
| March 31, 2026 | 24.33M |
| December 31, 2025 | 27.81M |
| September 30, 2025 | 28.56M |
| June 30, 2025 | 29.67M |
| March 31, 2025 | 29.60M |
| December 31, 2024 | 33.60M |
| September 30, 2024 | 32.22M |
| June 30, 2024 | 27.73M |
| March 31, 2024 | 27.88M |
| December 31, 2023 | 28.53M |
| September 30, 2023 | 24.27M |
| June 30, 2023 | 25.73M |
| March 31, 2023 | 30.98M |
| December 31, 2022 | 30.28M |
| September 30, 2022 | 27.50M |
| June 30, 2022 | 26.99M |
| March 31, 2022 | 32.00M |
| December 31, 2021 | 27.50M |
| September 30, 2021 | 27.55M |
| June 30, 2021 | 22.75M |
| March 31, 2021 | 21.23M |
| December 31, 2020 | 23.91M |
| September 30, 2020 | 19.15M |
| June 30, 2020 | 18.84M |
| Date | Value |
|---|---|
| March 31, 2020 | 19.56M |
| December 31, 2019 | 27.49M |
| September 30, 2019 | 26.56M |
| June 30, 2019 | 6.506M |
| March 31, 2019 | 9.648M |
| December 31, 2018 | 8.473M |
| September 30, 2018 | 8.536M |
| June 30, 2018 | 6.305M |
| March 31, 2018 | 4.775M |
| December 31, 2017 | 4.574M |
| September 30, 2017 | 3.324M |
| June 30, 2017 | 3.128M |
| March 31, 2017 | 3.537M |
| December 31, 2016 | 3.538M |
| September 30, 2016 | 3.520M |
| June 30, 2016 | 3.366M |
| March 31, 2016 | 2.910M |
| December 31, 2015 | 3.326M |
| September 30, 2015 | 2.655M |
| June 30, 2015 | 2.353M |
| March 31, 2015 | 2.105M |
| December 31, 2014 | 2.503M |
| September 30, 2014 | 2.087M |
| June 30, 2014 | 1.990M |
| March 31, 2014 | 4.027M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.873M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 47.54M |
| Shareholders Equity (Quarterly) | 37.89M |
| Debt to Equity Ratio | 0.0038 |
| Current Ratio | 4.842 |
| Net Debt Paydown Yield | 2.40% |